• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子诱饵:解毒剂、治疗剂和免疫调节剂。

Molecular decoys: antidotes, therapeutics and immunomodulators.

作者信息

Gershoni Jonathan M

机构信息

Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel.

出版信息

Curr Opin Biotechnol. 2008 Dec;19(6):644-51. doi: 10.1016/j.copbio.2008.10.001. Epub 2008 Nov 18.

DOI:10.1016/j.copbio.2008.10.001
PMID:18977299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7127390/
Abstract

Receptor-ligand interactions are fundamental to the regulation of cell physiology, enabling the communication between cells and their environment via signal transduction. Receptors are also exploited by toxins and infectious agents to mediate pathogenesis. Over the past 20 years, however, this bi-partite paradigm for cellular regulation, that is, receptors and their ligands, has been revised to include an unforeseen participant namely, soluble receptors or molecular decoys. Decoys function as nature's modifiers of potent responses such as inflammation, stimulation of cell proliferation and triggering apoptosis. Decoys not only provide the means to fine tune the regulation of these phenomena; they also serve as potential leads for the development of recombinant anti-toxins, anti-viral agents and novel therapeutics for combating cancer and inflammatory disease.

摘要

受体 - 配体相互作用是细胞生理学调节的基础,通过信号转导实现细胞与其环境之间的通讯。毒素和传染因子也利用受体来介导发病机制。然而,在过去20年中,这种细胞调节的二元模式,即受体及其配体,已被修订为包括一个意想不到的参与者,即可溶性受体或分子诱饵。诱饵作为强大反应(如炎症、细胞增殖刺激和触发细胞凋亡)的天然调节剂发挥作用。诱饵不仅提供了微调这些现象调节的手段;它们还作为开发重组抗毒素、抗病毒药物以及对抗癌症和炎症性疾病的新型疗法的潜在线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bf6/7127390/81d502b39fb4/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bf6/7127390/81d502b39fb4/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bf6/7127390/81d502b39fb4/gr1_lrg.jpg

相似文献

1
Molecular decoys: antidotes, therapeutics and immunomodulators.分子诱饵:解毒剂、治疗剂和免疫调节剂。
Curr Opin Biotechnol. 2008 Dec;19(6):644-51. doi: 10.1016/j.copbio.2008.10.001. Epub 2008 Nov 18.
2
Antidote control of aptamer therapeutics: the road to a safer class of drug agents.抗体解毒剂控制适体疗法:通往更安全药物制剂的道路。
Curr Pharm Biotechnol. 2012 Aug;13(10):1924-34. doi: 10.2174/138920112802273137.
3
Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.天然化合物及其类似物作为对抗最毒细菌毒素的有效解毒剂。
Appl Environ Microbiol. 2018 Nov 30;84(24). doi: 10.1128/AEM.01280-18. Print 2018 Dec 15.
4
Aptamers: an emerging class of therapeutics.适体:一类新兴的治疗药物。
Annu Rev Med. 2005;56:555-83. doi: 10.1146/annurev.med.56.062904.144915.
5
[Pharmacological correction of nonspecific resistance and production of proinflammatory cytokines during chronic intoxication with organophosphorus compound VX].[有机磷化合物VX慢性中毒期间非特异性抵抗力的药理纠正及促炎细胞因子的产生]
Eksp Klin Farmakol. 2012;75(11):19-21.
6
Corticosteroids as immunomodulators.作为免疫调节剂的皮质类固醇。
Ann N Y Acad Sci. 1993 Jun 23;685:288-92. doi: 10.1111/j.1749-6632.1993.tb35877.x.
7
Virus-encoded chemokine receptors--putative novel antiviral drug targets.病毒编码的趋化因子受体——潜在的新型抗病毒药物靶点。
Neuropharmacology. 2005 Jan;48(1):1-13. doi: 10.1016/j.neuropharm.2004.09.017.
8
Polymer antidotes for toxin sequestration.聚合物解毒剂用于毒素隔离。
Adv Drug Deliv Rev. 2015 Aug 1;90:81-100. doi: 10.1016/j.addr.2015.05.011. Epub 2015 May 27.
9
The basics and advances of immunomodulators and antigen presentation: a key to development of potent memory response against pathogens.免疫调节剂与抗原呈递的基础与进展:针对病原体产生有效记忆反应的关键
Expert Opin Biol Ther. 2014 Oct;14(10):1383-97. doi: 10.1517/14712598.2014.925871. Epub 2014 Jun 4.
10
Modulating apoptosis pathways in low-grade B-cell malignancies using biological response modifiers.使用生物反应调节剂调节低度B细胞恶性肿瘤中的凋亡途径。
Semin Oncol. 2002 Feb;29(1 Suppl 2):10-24.

引用本文的文献

1
Decoy receptors as biomarkers for exploring aetiology and designing new therapies.诱饵受体作为探索病因和设计新疗法的生物标志物。
Clin Kidney J. 2024 Jul 18;17(8):sfae222. doi: 10.1093/ckj/sfae222. eCollection 2024 Aug.
2
SARS-CoV-2 Binding and Neutralization Properties of Peptides Derived from N-Terminus of Human ACE2.SARS-CoV-2 与人 ACE2 N 端肽段的结合与中和特性
Int J Mol Sci. 2023 May 5;24(9):8269. doi: 10.3390/ijms24098269.
3
Interference in melanoma CD248 function reduces vascular mimicry and metastasis.干扰黑色素瘤 CD248 功能可减少血管拟态和转移。

本文引用的文献

1
Adalimumab, etanercept and infliximab are equally effective treatments for patients with psoriatic arthritis.阿达木单抗、依那西普和英夫利昔单抗对银屑病关节炎患者的治疗效果相同。
Nat Clin Pract Rheumatol. 2008 Oct;4(10):510-1. doi: 10.1038/ncprheum0880. Epub 2008 Aug 12.
2
Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.利洛纳塞(白细胞介素-1陷阱)治疗冷吡啉相关周期性综合征患者的疗效和安全性:两项连续安慰剂对照研究的结果
Arthritis Rheum. 2008 Aug;58(8):2443-52. doi: 10.1002/art.23687.
3
Aflibercept: AVE 0005, AVE 005, AVE0005, VEGF Trap - Regeneron, VEGF Trap (R1R2), VEGF Trap-Eye.
J Biomed Sci. 2022 Nov 18;29(1):98. doi: 10.1186/s12929-022-00882-3.
4
A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review.关于正在进行的新型冠状病毒(COVID-19)大流行的潜在预防措施、疫苗和治疗手段的范围性洞察——全面综述
Front Pharmacol. 2021 Feb 26;11:590154. doi: 10.3389/fphar.2020.590154. eCollection 2020.
5
Directed evolution of a soluble human DR3 receptor for the inhibition of TL1A induced cytokine secretion.定向进化可溶性人 DR3 受体抑制 TL1A 诱导的细胞因子分泌。
PLoS One. 2017 Mar 9;12(3):e0173460. doi: 10.1371/journal.pone.0173460. eCollection 2017.
6
Ganglioside embedded in reconstituted lipoprotein binds cholera toxin with elevated affinity.神经节苷脂嵌入再构成的脂蛋白中可提高与霍乱毒素的亲和力。
J Lipid Res. 2010 Sep;51(9):2731-8. doi: 10.1194/jlr.M007401. Epub 2010 May 14.
阿柏西普:AVE 0005、AVE 005、AVE0005、VEGF Trap - 再生元、VEGF Trap(R1R2)、VEGF Trap - 眼用制剂
Drugs R D. 2008;9(4):261-9. doi: 10.2165/00126839-200809040-00006.
4
The TNF Superfamily-2008.肿瘤坏死因子超家族 - 2008年
Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):183-6. doi: 10.1016/j.cytogfr.2008.05.001.
5
Decoy oligodeoxynucleotide targeting activator protein-1 (AP-1) attenuates intestinal inflammation in murine experimental colitis.靶向活化蛋白-1(AP-1)的诱饵寡脱氧核苷酸可减轻小鼠实验性结肠炎中的肠道炎症。
Lab Invest. 2008 Jun;88(6):652-63. doi: 10.1038/labinvest.2008.38. Epub 2008 May 5.
6
Nicotinic receptors, allosteric proteins and medicine.烟碱型受体、变构蛋白与医学
Trends Mol Med. 2008 Mar;14(3):93-102. doi: 10.1016/j.molmed.2008.01.001. Epub 2008 Feb 11.
7
Structure and mechanism of IFN-gamma antagonism by an orthopoxvirus IFN-gamma-binding protein.正痘病毒干扰素-γ结合蛋白对干扰素-γ的拮抗作用的结构与机制
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):1861-6. doi: 10.1073/pnas.0705753105. Epub 2008 Feb 5.
8
Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.在小鼠中阻断肿瘤坏死因子-α可减少与慢性结肠炎相关的结直肠癌发生。
J Clin Invest. 2008 Feb;118(2):560-70. doi: 10.1172/JCI32453.
9
Tumor necrosis factor antagonist mechanisms of action: a comprehensive review.肿瘤坏死因子拮抗剂的作用机制:全面综述
Pharmacol Ther. 2008 Feb;117(2):244-79. doi: 10.1016/j.pharmthera.2007.10.001. Epub 2007 Oct 26.
10
Marked regression of liver metastasis by combined therapy of ultrasound-mediated NF kappaB-decoy transfer and transportal injection of paclitaxel, in mouse.超声介导的核因子κB诱饵转移与经门静脉注射紫杉醇联合治疗对小鼠肝转移的显著消退作用
Int J Cancer. 2008 Apr 1;122(7):1645-56. doi: 10.1002/ijc.23280.